ScholarIQanswers from OpenAlex

Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation

PaperCitations, authors & open-access status

Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation have?

ScholarIQcitation count

Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation has 190 citations in the OpenAlex counts ScholarIQ stores.

When was Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation published?

ScholarIQyear

Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation has 2019 year in the ScholarIQ index.

What is the open-access status of Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation?

ScholarIQoa status

Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation has green oa status in the ScholarIQ index.

What is the DOI of Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation?

ScholarIQdoi

The DOI for Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation is on the source record.

What is the PMID of Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation?

ScholarIQpmid

The PMID for Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation is on the source record.

What is the OpenAlex record for Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation?

ScholarIQopenalex

The OpenAlex for Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial